Vasanthavada Madhav sold 4,902 shares of ABEONA THERAPEUTICS INC. at $5.16 for −$25.3k on Sep 29, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Commercial Officer
Chief Commercial Officer
Filed Sep 29, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$25,272.75Shares × reported price
Shares traded
4,902Common Stock
Price per share
$5.16Reported price. Read footnotes for ranges.
% of reported position traded
1.69%This security and ownership context
Holdings after
285,721Direct
Trade date
Sep 29, 2026Sell
Filed
Sep 29, 2026, 9:47 PM ET1-day reporting delay
Accession
0001493152-26-044971Code S · Transaction 231498
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 290,623 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ABEO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ABEO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +13%1w ago +11%1d ago +0.8%
Returns since7d −3.2%30d −13%90d180d1y

Footnotes in full

F1: The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1150 to $5.3000 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.